Boomerang Ventures

Boomerang Ventures
Menu
STUDIO APPLICATION
FUND APPLICATION
SynchNeuro Gains Seed-Stage Support from Boomerang Ventures | StartUp Health Insights
In the News
Source: Startup Health SynchNeuro has secured seed-stage support from Boomerang Ventures to advance its brain-based, non-invasive continuous glucose monitoring technology. Using EEG-derived signals decoded by machine learning, the company is developing a wearable “Cardiometabolic Advisor” that tracks blood glucose and metabolic indicators without needles. The investment accelerates development and moves the device closer to broad market adoption.

SynchNeuro is a Boomerang Ventures Portfolio Company

Source: Startup Health

Boomerang Ventures is backing StartUp Health community member SynchNeuro’s pioneering effort to build the world’s first brain-based, non-invasive continuous glucose monitor. Other investments this week ranged from AI-enabled preventive care and protein engineering to emergency response tech, care orchestration, women’s health, and next-gen biotech tools.

Casey Halpern, MD, and Emily Mirro, Co-founders of SynchNeuro

StartUp Health community member SynchNeuro has received backing from Boomerang Ventures. Using EEG-derived brainwave signals decoded by machine learning, SynchNeuro aims to track blood glucose and cardiometabolic indicators via a discreet wearable placed behind the ear. This seed investment will help speed development of the “Cardiometabolic Advisor” system and bring proactive, needle-free monitoring closer to the mass market.

Source: Startup Health, November 25, 2025, Nicole Kinsey

Read more

Boomerang Ventures
Loading...